Global Health Economics Director, CCVP

About the role

The Director, Health Economics is a senior cross-functional leadership role responsible for developing and executing global growth strategy and long-range financial and value planning for Advanced Oncology Solutions Cancer Care Value Programs (CCVP), including radiation oncology, theranostics, and related products and services.

Responsibilities

• Develop and lead the multi-year CCVP strategic and financial roadmap, ensuring alignment with corporate growth, profitability, and market expansion objectives.
• Define, implement, and continuously refine a global KPI framework to measure: Revenue growth and margin performance of CCVP deals, Value realization for customers (e.g., cost savings, throughput, outcomes), Market access milestones (coverage, reimbursement levels, policy wins), Adoption and utilization rates of oncology solutions.
• Lead performance reviews of CCVP partnerships, identifying risks, opportunities, and corrective actions to optimize ROI.
• Build health-system-specific economic models and ROI frameworks to support large-scale Value Partnership deals, including multi-year agreements with IDNs and government health authorities.
• Partner with Finance to integrate KPIs into budgeting, forecasting, and long-range planning processes, ensuring alignment between strategic objectives and financial outcomes.
• Support reimbursement strategy and coding initiatives (e.g., CPT/APC codes), collaborating with Government Affairs on CMS engagement and advocacy.
• Collaborate with Digital Health and AI teams to develop and validate outcomes evidence for AI-driven oncology solutions and workflow optimization tools.
• Drive adoption of advanced analytics to enable predictive performance monitoring and continuous improvement of CCVP offerings.
• Serve as a strategic partner across functions, ensuring alignment on goals, metrics, and performance tracking.
• Lead governance forums to review KPIs, assess progress, and drive decision-making across global stakeholders.

Qualifications

• Advanced degree in a health, business, or quantitative discipline with direct application to healthcare economics, finance, or outcomes measurement.
• MBA with 10+ years of progressive healthcare finance leadership within large, complex IDNs.
• 8+ years of progressive experience in strategic healthcare finance, health economics, or outcomes research; demonstrated leadership scope equivalent to director level — owning multi-hundred-million-dollar P&Ls, advising C-suite executives, and driving enterprise decision-making.
• Demonstrated expertise building sophisticated financial models for complex oncology programs — including cost-per-case analyses, ROI and pro forma models, multi-scenario forecasting, budget impact frameworks, and service line economics.
• Proficiency in advanced Excel, BI tools (Power BI, Essbase, or equivalent), and data visualization.
• Deep knowledge of U.S. healthcare economics and reimbursement — including Medicare/Medicaid (CMS), commercial payers, hospital value analysis committees (VACs), and IDN procurement processes.
• Hands-on experience analyzing payer mix impact, reimbursement variability, and revenue optimization across clinical programs.
• Strong understanding of oncology care pathways and the clinical and operational factors that drive financial performance — including radiation oncology economics (linear accelerator utilization, fraction volume, capital intensity), infusion economics, and specialty pharmacy.
• Proven track record supporting large, complex strategic deals and partnerships with health-economic evidence and ROI tools — including multi-year, multi-site program economics, capital investment justification, and performance modeling.
• Outstanding executive communication and storytelling ability — translating complex financial and clinical-economic data into clear, compelling narratives for CFO, CMO, COO, CEO, and CEO level stakeholders.
• Demonstrated ability to influence strategic decisions without direct authority across matrixed organizations.
• Experience partnering with clinical and operational leadership on strategic planning — including scenario-based planning, service line growth strategy, access expansion, and efficiency initiatives.
• International healthcare economics experience and cross-cultural stakeholder engagement.